Patents and Patent Costs. 4.1 Licensee agrees that, as between the parties, PTI retains all right, title and interest in and to the Licensed Technology, the Know-how and the Licensed Patents outside the Territory. Licensee agrees never to challenge (a) PTI's ownership of the Licensed Technology, the Know-how and the Licensed Patents and (b) the license to PTI set forth in Paragraph 2.7.
Patents and Patent Costs. 4.1 MSU shall retain title to the Technology, Know-how, and the Patents.
Patents and Patent Costs. 4.1 CHRF shall retain title to the Technology, the Know-how and the Patents.
Patents and Patent Costs. 4.1 DKL shall retain title to the Technology, Know-how, and the Patents.
Patents and Patent Costs. 4.1 LICENSOR shall retain title to the Technology, Know-how, and the Patents.
Patents and Patent Costs. 7.1 LICR and MPI shall consult and agree on the filing of U.S. and international patent applications covering SRP Joint Materials or SRP Joint Technology. MPI shall have the responsibility of filing, prosecuting and maintaining patent applications and patents included in SRP Joint Patent Rights and shall provide LICR with copies of all Patent Office correspondence in all patent applications included in SRP Joint Patent Rights in sufficient time to provide comments. Each party will provide the other with Patent Office correspondence in respect of LICR Patent Rights, SRP Joint Patent Rights and FRP Joint Patent Rights, as the case may be, in sufficient time to provide comments. The party responsible for handling such patent rights will provide the other with a status report in writing by facsimile on or about March 15 and September 15 of each year starting with 2001. ________________________ ** Certain portions of this exhibit have been omitted based upon a request for confidential treatment that has been filed with the Commission. The omitted portions have been filed separately with the Commission.
Patents and Patent Costs. 4.1 LICR at its expense shall be responsible for prosecuting and maintaining patent applications and patents included in LICR Patent Rights set forth in Amended Appendix A. From and after December 20, 1999, MPI will reimburse LICR for the [**] included in LICR Patent Rights. The cost of [**] such patents will be prorated in equal portions among licensees in the event LICR grants any new licenses for therapeutic use under LICR Patent Rights outside the Field.
Patents and Patent Costs. 4.1 Patents will be owned by UC if invented only by UC Inventors; by SHC if invented only by SHC Inventors; and by Cutanogen if invented only by Cutanogen Inventors. Patents will be jointly owned by UC, SHC and/or Cutanogen if jointly invented by UC. SHC and/or Cutanogen Inventors respectively. Inventors is defined under US patent law.
Patents and Patent Costs. 4.1 Company shall retain title to the Licensed Technology, the Know-how and the Licensed Patents.
Patents and Patent Costs. 4.1 The parties shall file, prosecute, and maintain the Patents and Improvements in the United States using patent counsel chosen by DKL, but jointly representing DrawDown and DKL (“Patent Counsel”). The parties will instruct Patent Counsel (i) to copy both parties on all communications received from or sent to a patent office respecting the Patents and Improvements; (ii) to confer with both parties respecting the patent prosecution strategy, including without limitation providing both parties a reasonable opportunity to comment in advance of all patent filings, all responses to office actions, and the designation of countries for which patents are sought; and (iii) to collaborate and agree on strategies with regard to claims directed to the Field, which agreement will not be unreasonably withheld by either party. DrawDown may propose to add non-designated countries for which DKL has pending applications, and the parties shall instruct Patent Counsel to add such countries.
